06.16.21
This Week’s EyewireTV
US Looks to Spur Advances in COVID-19 Antivirals With $3.2-Billion Infusion
Source: FirstWord
Two Shots of Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Delta Variant: Study
Source: FiercePharma
OcuGen to No Longer Pursue EUA for Covid-19 Vaccine Candidate Covaxin; Will Pursue Full Approval
Source: Ocugen
Latest News
06.18.21
Iveric Bio to Present Zimura GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc AnalysesSource: Iveric Bio
06.18.21
US Looks to Spur Advances in COVID-19 Antivirals With $3.2-Billion InfusionSource: FirstWord
06.18.21
Santen to Host Dry Eye Disease Panel at Inaugural European Dry Eye Society Congress (EuDEC)Source: Santen
06.17.21
Scientists Unravel the Function of a Sight-Saving Growth FactorSource: National Eye Institute
06.17.21
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in JapanSource: Aerie Pharmaceuticals
06.16.21
The Vision Council Releases Results of the 2020 Internet Influence ReportSource: The Vision Council
06.16.21
The Retina Center, of Minneapolis and St. Paul, Joins Retina Consultants of AmericaSource: Retina Consultants of America
06.15.21
Johnson & Johnson Vision Holds Tecnis 20th Anniversary Charitable Art AuctionSource: Johnson & Johnson Vision
06.15.21
Two Shots of Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Delta Variant: StudySource: FiercePharma
06.15.21
Market Scope: Ophthalmic Laser Market Expected to Total $376.4 Million in 2021Source: Market Scope
06.15.21
CORE Summarizes BCLA CLEAR Guidance for Contact Lens PractitionersSource: Centre for Ocular Research & Education
06.15.21
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Trial of CLS-AX for the Treatment of Wet AMDSource: Clearside Biomedical
